Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04579900
NA

Dissecting Host-microbiome Modifiers of Type 2 Diabetes Risk

Sponsor: Laval University

View on ClinicalTrials.gov

Summary

It is now well documented that changes in gut microbiota composition accompany obesity and type 2 diabetes (T2D) and contribute to low-grade inflammation, insulin resistance,and glucose intolerance. It is not yet clear if T2D predisposes the intestine to allow more microbial products or possibly live bacteria to subvert the gut mucosal barrier. However, it is known that hyperglycemia during T2D induces a more permissive gut barrier allowing increased penetration of microbes and their products into the blood. An important next step is to determine which strains of bacteria promote dysbiosis, allowing bacteria or bacterial components to subvert the gut barrier and alter glucose control. It is hypothesized that gut microbes in the colon and other lower gut segments are key modulators of energy balance, glucose homeostasis and insulin sensitivity.

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2021-02-01

Completion Date

2025-12-01

Last Updated

2025-03-18

Healthy Volunteers

Yes

Conditions

Interventions

PROCEDURE

Endoscopy and duodenal biopsy and sampling

All volunteers will have endoscopy and duodenal biopsy and will have to provide stool samples

Locations (1)

INAF, Université Laval

Québec, Quebec, Canada